Literature DB >> 16350561

Gallstone formation and weight loss.

R L Weinsier1, D O Ullmann.   

Abstract

Obesity is associated with increased bile stasis and cholesterol saturation, and an increased risk of gallstone development. Conversely, bile composition is normalized following reduction in body weight. It would appear advantageous to promote weight loss in obesity, which would reduce the predisposition to gallstone formation. Despite the potential health benefits of weight reduction, very-low-calorie diets appear to increase the risk for cholesterol crystal and gallstone formation. The incidence of gallstone formation seems to be dependent on the degree of caloric restriction, the rate of weight loss, and the duration of the dietary intervention. Thus, faster rates of weight loss for longer periods of time are associated with increased risk. Available data obtained from prospective studies of subjects during active weight loss suggest that newly formed gallstones occur within 4 weeks and with incidence rates 15 to 25-fold higher than in the general obese population. The stones produce symptoms in approximately one-third of the subjects, of whom approximately one-half will undergo surgery. Proposed mechanisms underlying gallstone formation during weight reduction include bile stasis due to reduced caloric intake, increased biliary cholesterol saturation secondary to increased cholesterol mobilization, and increased nucleation due to changes in bile arachidonate and glycoprotein concentrations. Data are lacking on the effects of gradual rates of weight loss and risk of gallstone formation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 16350561     DOI: 10.1002/j.1550-8528.1993.tb00008.x

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  9 in total

1.  Prophylactic cholecystectomy, a mandatory step in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass?

Authors:  Mathieu D'Hondt; Gregory Sergeant; Bert Deylgat; Dirk Devriendt; Frank Van Rooy; Franky Vansteenkiste
Journal:  J Gastrointest Surg       Date:  2011-07-13       Impact factor: 3.452

Review 2.  Management of gallstones and gallbladder disease in patients undergoing gastric bypass.

Authors:  Bernabé M Quesada; Gustavo Kohan; Hernán E Roff; Carlos M Canullán; Luis T Chiappetta Porras
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

3.  Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial.

Authors:  Thomas A Wadden; John P Foreyt; Gary D Foster; James O Hill; Samuel Klein; Patrick M O'Neil; Michael G Perri; F Xavier Pi-Sunyer; Cheryl L Rock; Janelle S Erickson; Holly N Maier; Dennis D Kim; Eduardo Dunayevich
Journal:  Obesity (Silver Spring)       Date:  2010-06-17       Impact factor: 5.002

4.  Peroxisome proliferator-activated receptor-gamma coactivator-1alpha activation of CYP7A1 during food restriction and diabetes is still inhibited by small heterodimer partner.

Authors:  Dong-Ju Shin; Timothy F Osborne
Journal:  J Biol Chem       Date:  2008-04-02       Impact factor: 5.157

5.  Is concomitant cholecystectomy necessary in obese patients undergoing laparoscopic gastric bypass surgery?

Authors:  O N Tucker; P Fajnwaks; S Szomstein; R J Rosenthal
Journal:  Surg Endosc       Date:  2008-02-21       Impact factor: 4.584

Review 6.  Clinical Practice Recommendations for the Management of Obesity in the United Arab Emirates.

Authors:  Salahedeen Abusnana; Mohammad Fargaly; Shaima Hasan Alfardan; Fatema Hasan Al Hammadi; Alaaeldin Bashier; Ghaida Kaddaha; Barbara McGowan; Rita Nawar; Amena Sadiya
Journal:  Obes Facts       Date:  2018-10-30       Impact factor: 3.942

Review 7.  Obesity: Risk factors, complications, and strategies for sustainable long-term weight management.

Authors:  Sharon M Fruh
Journal:  J Am Assoc Nurse Pract       Date:  2017-10       Impact factor: 1.495

8.  Symptomatic gallstones and HIV in black South African women: Changing trends of gallstone disease?

Authors:  Suman Mewa Kinoo; Savania Nagiah; Anil Chuturgoon; Bhugwan Singh
Journal:  South Afr J HIV Med       Date:  2021-03-25       Impact factor: 2.744

9.  Epidemiology of gallbladder disease: cholelithiasis and cancer.

Authors:  Laura M Stinton; Eldon A Shaffer
Journal:  Gut Liver       Date:  2012-04-17       Impact factor: 4.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.